- Asked by: Mark Ruskell, MSP for Mid Scotland and Fife, Scottish Green Party
-
Date lodged: Tuesday, 06 July 2004
-
Current Status:
Answered by Malcolm Chisholm on 29 July 2004
To ask the Scottish Executive what information is publicly available about the ethical oversight of healthy volunteers participating in human clinical trials of non-pharmaceutical substances at Inveresk research laboratories.
Answer
This information is not held centrally.
- Asked by: Mark Ruskell, MSP for Mid Scotland and Fife, Scottish Green Party
-
Date lodged: Tuesday, 06 July 2004
-
Current Status:
Answered by Malcolm Chisholm on 29 July 2004
To ask the Scottish Executive whether issues of commercial confidentiality prevent ethical oversight and regulation of healthy volunteers participating in human clinical trials of non-pharmaceutical substances at Inveresk research laboratories.
Answer
I refer the member to the answer given to question S2W-9588 answered 29 July 2004 which is available on the Parliament’s website, the search facility for which can be found at
http://www.scottish.parliament.uk/webapp/search_wa.
- Asked by: Mark Ruskell, MSP for Mid Scotland and Fife, Scottish Green Party
-
Date lodged: Tuesday, 06 July 2004
-
Current Status:
Answered by Malcolm Chisholm on 29 July 2004
To ask the Scottish Executive whether consideration of applications to carry out human clinical trials on healthy volunteers at Inveresk research laboratories should be considered by an ethical committee other than the Edinburgh Independent Ethics Committee for Medical Research.
Answer
Any committee recognised to cover the same type (type (i) recognition) and geographical area could be asked to consider applications for ethical review from Inveresk research laboratories.
- Asked by: Mark Ruskell, MSP for Mid Scotland and Fife, Scottish Green Party
-
Date lodged: Tuesday, 06 July 2004
-
Current Status:
Answered by Malcolm Chisholm on 29 July 2004
To ask the Scottish Executive what information is publicly available about the regulation of healthy volunteers participating in human clinical trials of non-pharmaceutical substances at Inveresk research laboratories.
Answer
Inveresk research laboratories is a private company. Any information should be sought from them.
- Asked by: Mark Ruskell, MSP for Mid Scotland and Fife, Scottish Green Party
-
Date lodged: Tuesday, 06 July 2004
-
Current Status:
Answered by Malcolm Chisholm on 29 July 2004
To ask the Scottish Executive whether healthy volunteers participating in human clinical trials of non-pharmaceutical substances at Inveresk research laboratories receive full information regarding their treatment.
Answer
Such information is not available to the Scottish Executive. Inveresk is a private company.
- Asked by: Mark Ruskell, MSP for Mid Scotland and Fife, Scottish Green Party
-
Date lodged: Wednesday, 23 June 2004
-
Current Status:
Answered by Allan Wilson on 21 July 2004
To ask the Scottish Executive when it expects to make commencement orders in respect of the Nature Conservation (Scotland) Act 2004 and which sections will come into force first.
Answer
As I made clear during parliamentary consideration of the act, commencement of this important legislation will not be unnecessarily delayed. My intention is that the act should be commenced later this year. It is likely that the provisions in part 3 of the act (Protection of Wildlife) will be the first to come into force.
- Asked by: Mark Ruskell, MSP for Mid Scotland and Fife, Scottish Green Party
-
Date lodged: Wednesday, 23 June 2004
-
Current Status:
Answered by Cathy Jamieson on 1 July 2004
To ask the Scottish Executive whether it anticipates any problems arising from the operation of the TETRA police telecommunication system.
Answer
The operation and maintenance of the Airwave network is a matter for the service provider O2. Scottish police forces and the Scottish Executive have been working closely with O2 with the aim of achieving a smooth migration from existing systems to Airwave.
In planning for the introduction of Airwave, Scottish forces have benefited from sharing information with those forces in England and Wales already using the service. This information has been used at both national and local levels to assist forces in preparing for Airwave.
- Asked by: Mark Ruskell, MSP for Mid Scotland and Fife, Scottish Green Party
-
Date lodged: Wednesday, 23 June 2004
-
Current Status:
Answered by Ross Finnie on 1 July 2004
To ask the Scottish Executive how the environmental impact of multiple proposed windfarm developments in a given area should be assessed.
Answer
Advice on how cumulative impacts should be assessed is given in Planning Advice Note 45: Renewable Energy Technologies.
- Asked by: Mark Ruskell, MSP for Mid Scotland and Fife, Scottish Green Party
-
Date lodged: Tuesday, 22 June 2004
-
Current Status:
Answered by Frank McAveety on 1 July 2004
To ask the Scottish Executive whether it will ensure that, in expanding the field sports sector of tourism, biodiversity and other land use interests are protected.
Answer
Scotland’s unrivalled natural beauty is one of the major assets that attracts visitors to choose Scotland as a holiday destination. The protection of these assets is therefore an essential element in our tourism strategy, and in the development of the tourism products that we offer our visitors.
- Asked by: Mark Ruskell, MSP for Mid Scotland and Fife, Scottish Green Party
-
Date lodged: Wednesday, 09 June 2004
-
Current Status:
Answered by Lewis Macdonald on 17 June 2004
To ask the Scottish Executive whether the Scottish Community Renewables Initiative will have adequate resources for funding renewable energy installation in new schools.
Answer
The Scottish Community and Householder Renewables Initiative supports a range ofapplicants, including schools, hospitals, community centres and local housinginitiatives. Applications are dealt with on a first-come, first-served basis. Extensive efforts are being made to promote the scheme to local authority clients, we are considering the options for extension of the scheme beyond 2005 as part of the current spending review.
